Trending

TiGenix

Takeda finalises buyout of TiGenix

Japanese pharma giant Takeda has completed its buyout of TiGenix. Takeda’s main R&D focus is in oncology, gastroenterology

X

Takeda finalises buyout of TiGenix

https://pharmaphorum.com/news/japanese-takeda-finalises-tigenix-boyout/

Takeda to buy stem cell specialists TiGenix for $626m

Takeda to buy stem cell specialists TiGenix for $626m

Decision follows EU regulators’ decision to back Crohn’s stem cell therapy

X

Takeda to buy stem cell specialists TiGenix for $626m

https://pharmaphorum.com/news/takeda-buy-gastro-biotech-tigenix-463m/

First ever ‘off the shelf’ stem cell therapy nears European approval

First ever ‘off the shelf’ stem cell therapy nears European approval

Alofisel recommended for complex perianal fistulas in Crohn’s disease

X

First ever ‘off the shelf’ stem cell therapy nears European approval

https://pharmaphorum.com/news/tigenixtakeda-stem-cell-therapy-backed-eu-regulators/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com